Changeflow GovPing Government & Legislation Blue Rabbit Veterinary LLC Controlled Substance...
Routine Notice Added Final

Blue Rabbit Veterinary LLC Controlled Substance Importer Application

Favicon for www.regulations.gov Regulations.gov Final Notices
Published April 2nd, 2026
Detected April 6th, 2026
Email

Summary

The DEA published notice that Blue Rabbit Veterinary LLC applied to be registered as an importer of Schedule II controlled substances Etorphine HCL (9059) and Thiafentanil (9729) for sale to veterinarians. The application was filed February 23, 2026, with comments on the registration due May 4, 2026.

What changed

DEA published notice pursuant to 21 CFR 1301.34(a) that Blue Rabbit Veterinary LLC (405 Heron Drive, Suite 300, Swedesboro, New Jersey) applied on February 23, 2026 to be registered as an importer of two Schedule II controlled substances: Etorphine HCL (drug code 9059) and Thiafentanil (drug code 9729). The company plans to import these substances for sale to veterinarians. The authorization will only extend to activities consistent with 21 U.S.C. 952(a)(2) and will not cover import of FDA-approved or non-approved finished dosage forms for commercial sale.

Registered bulk manufacturers and applicants may submit electronic comments or objections, or request a hearing, on or before May 4, 2026. All comments must be submitted via regulations.gov. Requests for hearing must be sent to the DEA Hearing Clerk/OALJ and DEA Federal Register Representative at 8701 Morrissette Drive, Springfield, Virginia 22152.

Source document (simplified)

Content

ACTION:

Notice of application.

SUMMARY:

Blue Rabbit Veterinary LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer
to
Supplementary Information
listed below for further drug information.

DATES:

Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on
or objections to the issuance of the proposed registration on or before May 4, 2026. Such persons may also file a written
request for a hearing on the application on or before May 4, 2026.

ADDRESSES:

The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file
for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive
a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit
the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ,
8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration,
Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.34(a), this is notice that on February 23, 2026, Blue Rabbit Veterinary LLC, 405 Heron Drive,
Suite 300, Swedesboro, New Jersey 08085-1749, applied to be registered as an importer of the following basic class(es) of
controlled substance(s):

| Controlled substance | Drug code | Schedule |
| --- | --- | --- |
| Etorphine HCL | 9059 | II |
| Thiafentanil | 9729 | II |
The company plans to import the listed controlled substances for sale to their customers (veterinarians). No other activities
for these drug codes are authorized for this registration.

Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved
finished dosage forms for commercial sale.

Thomas Prevoznik, Deputy Assistant Administrator. [FR Doc. 2026-06520 Filed 4-2-26; 8:45 am] BILLING CODE 4410-09-P

Download File

Download

CFR references

21 CFR 1301.34(a)

Classification

Agency
DEA
Published
April 2nd, 2026
Comment period closes
May 4th, 2026 (28 days)
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
FR Doc. 2026-06520
Docket
DEA-2026-0630

Who this affects

Applies to
Pharmaceutical companies Importers and exporters Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Controlled Substance Importing DEA Registration
Threshold
Importation of Etorphine HCL (9059) and Thiafentanil (9729) only; no other activities authorized for these drug codes
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Compliance, Legal
Topics
Controlled Substances Import/Export Healthcare

Get Government & Legislation alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when Regulations.gov Final Notices publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.